BioSpace News Archive

Almac Group today announced a 15-year virtual power purchase agreement (VPPA) with renewable energy provider

The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie (NYSE: ABBV) has expanded its collaboration to further explore Calibr-Skaggs’ switchable CAR-T (sCAR-T) platform in solid tumor indications and autoimmune diseases.

SMC Laboratories, Inc. (“SMC Laboratories”) recently launched their innovative STAM™-HCC/IO+ mouse – a first in the field of tumor immuno-oncology – to develop new liver cancer therapeutic drugs.

Conformal Medical, Inc. announced that the company’s CLAAS® System was featured in a live case presentation during the 29th Annual AF Symposium.

icotec ag is pleased to announce the appointment of Christoph Eigenmann as its new CEO for the United States.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

KARL STORZ announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed.

89bio, Inc. announced that the Company’s Management will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024 at 1:20 PM EST and participate in one-on-one investor meetings.

Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 33,750 restricted stock units of Arcutis’ common stock to five newly hired employees.

Apellis Pharmaceuticals, Inc. announced that the company approved the grant of equity awards to 4 new employees with a grant date of February 1, 2024, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.